Analytical Size-Exclusion Chromatography with In-Line Multi-Angle Light Scattering (SEC-MALS) for Oligomeric State Determination of a Purified Protein

Single-injection analytical runs of 50-100 µg protein on a calibrated SEC-MALS system, with n=3 independent injections (technical replicates) and ideally n=2-3 protein lots (biological replicates). A BSA standard injection precedes samples to normalize MALS detectors and validate the dn/dc and band-broadening parameters. Isocratic elution at a fixed flow rate; UV (280 nm), MALS (multi-angle), and dRI collected in-line. Concentration-dependence (e.g. 0.5, 1, 2 mg/mL load) optionally probes self-association.

BSL-1 for recombinant protein. Hazards: sodium azide (NaN3) in buffers is acutely toxic and forms explosive metal azides in plumbing/drains — never pour azide buffers down the sink; collect as hazardous waste and flush lines with copious water. Ethanol (column storage) is flammable. TCEP is a mild irritant. PPE: lab coat, nitrile gloves, safety glasses. Use HPLC-grade solvents; manage system pressure within column limits to avoid bursts.

BSA monomer standard: normalizes MALS detector angles and validates the system (expected 66.5 kDa monomer + ~133 kDa dimer shoulder). Buffer-blank injection: confirms a clean baseline with no leaching/particulate peaks. dn/dc reference: protein dn/dc = 0.185 mL/g assumed (or measured) — verify against UV-derived concentration. A known-MW protein standard of similar size confirms column/flow performance and resolution.

A single symmetric peak with a flat horizontal molar-mass trace across its width (sign of monodispersity), Mw within ±5-10% of an integer multiple of the predicted monomer mass. Polydispersity Mw/Mn ≈ 1.00-1.05. High-MW aggregate (void peak) <5% of total UV area. A rising mass trace across the peak or a void shoulder indicates aggregation or concentration-dependent self-association.

• Purified protein, ≥1 mg/mL, 0.22 µm-filtered and clarified (20,000 × g, 10 min, 4 °C)
• Analytical SEC column appropriate to MW range (e.g. Superdex 200 Increase 10/300 GL or Superose 6 Increase)
• Running buffer: 25 mM HEPES pH 7.5, 150 mM NaCl, 0.5 mM TCEP, 0.02% NaN3 — 0.1 µm filtered and degassed
• BSA monomer standard (2 mg/mL) for detector normalization
• In-line MALS detector (e.g. Wyatt DAWN) + dRI detector (Optilab) downstream of the FPLC UV
• 0.1 µm in-line filter; HPLC-grade water; protein dn/dc value 0.185 mL/g (default)

To measure the solution molar mass and homogeneity of a purified protein by SEC-MALS, in which a Superdex/Superose analytical column separates species by size and in-line UV, MALS, and differential refractive index (dRI) detectors yield the absolute, calibration-independent molar mass of each eluting peak. The objective is to assign monomer/dimer/higher-order state, quantify % aggregate, and assess sample monodispersity for downstream studies.

1. Filter (0.1 µm) and extensively degas the running buffer; equilibrate the column + MALS/dRI train for ≥2 column volumes until UV, MALS, and dRI baselines are flat and stable.
2. Inject 50 µg BSA standard; verify the monomer peak reads ~66.5 kDa and normalize the MALS detectors, align UV/MALS/dRI peaks, and fit band-broadening in ASTRA.
3. Clarify the protein sample (20,000 × g, 10 min, 4 °C); load 50-100 µg in ≤100 µL.
4. Run isocratically at the column-rated flow (e.g. 0.5 mL/min for Superdex 200 Increase 10/300) at room temperature or 4 °C.
5. Collect UV280, MALS (all angles), and dRI continuously through the full elution.
6. Repeat for n=3 injections; optionally vary load concentration to test self-association.
7. Flush and store the column in 20% ethanol or 0.02% azide buffer after the run.

Independent: protein sample identity and (optionally) load concentration. Dependent: MALS-derived molar mass (Mw) per peak, peak retention volume, polydispersity (Mw/Mn), and % aggregate. Controlled: running buffer composition, flow rate, injection mass/volume, temperature, dn/dc (0.185 mL/g), and detector normalization (set by the BSA run).

A well-folded, properly purified protein will elute as a single symmetric, monodisperse peak whose MALS-derived molar mass matches an integer multiple of the sequence-predicted monomer mass (within ±5-10%), with a flat mass distribution across the peak (polydispersity Mw/Mn ≈ 1.0) and <5% high-molecular-weight aggregate in the void.

Process in Wyatt ASTRA (or equivalent): define peak baselines, apply the BSA-derived detector normalization, band-broadening, and inter-detector delay; compute absolute molar mass from the Zimm/Debye fit using MALS intensity and dRI-derived concentration (with dn/dc). Report Mw, Mn, Mw/Mn per peak and the mass distribution across the peak. Quantify aggregate as % of total area. Cross-check concentration via UV280 and ε280.

1. Noisy/drifting MALS baseline: particulates or bubbles — re-filter (0.1 µm) and degas buffer, install/replace in-line filter, re-equilibrate longer. 2. Rising mass trace across a peak: aggregation or self-association — clarify sample harder, lower load, test a different buffer/pH. 3. Mw far off predicted: wrong dn/dc or bad detector alignment — re-run BSA normalization, verify concentration by UV/ε280. 4. Void-volume peak dominates: aggregated sample — spin-clarify, add reducing agent or stabilizer, re-purify. 5. Poor resolution / peak tailing: column fouled or overloaded — clean/replace column, reduce injection mass.

Mw per peak reported as mean ± SD across n=3 injections (and across protein lots where available). Inter-injection CV on Mw is typically <2-3%. Oligomeric-state assignment judged by whether mean Mw ± SD spans an integer multiple of monomer mass. Concentration-dependence of Mw (self-association) assessed by linear regression of Mw vs load; slope tested against zero (α=0.05).